We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The generic drug market could get a boost from an FDA challenge to a recent court decision providing two generic manufacturers with 180 days of market exclusivity for their version of the cholesterol-lowering drug Zocor.